Publikation

The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program.

Wissenschaftlicher Artikel/Review - 14.04.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Jungblut L, von Garnier C, Puhan M, Tomonaga Y, Kaufmann C, Azzola A, Bürgi U, Bremerich J, Brutsche M, Christe A, Ebner L, Heverhagen J, Eich C, Franzen D, Schmitt-Opitz I, Schneiter D, Spieldenner J, Horwath N, Kohler M, Weder W, Lovis A, Meuli R, Menig M, Beigelmann-Aubry C, Niemann T, Stöhr S, Vock P, Senn O, Neuner-Jehle S, Selby K, Laures S, Otto S, Frauenfelder T. The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program. Swiss Med Wkly 2022; 152
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Swiss Med Wkly 2022; 152
Veröffentlichungsdatum
14.04.2022
eISSN (Online)
1424-3997
Kurzbeschreibung/Zielsetzung

Lung cancer is the leading cause of cancer-related deaths in Switzerland. Despite this, there is no lung cancer screening program in the country. In the United States, low-dose computed tomography (LDCT) lung cancer screening is partially established and endorsed by guidelines. Moreover, evidence is growing that screening reduces lung cancer-related mortality and this was recently shown in a large European randomized controlled trial. Implementation of a lung cancer screening program, however, is challenging and depends on many country-specific factors. The goal of this article is to outline a potential Swiss lung cancer screening program.